To determine the efficacy and safety of robotic, laparoscopic and open surgery for enucleation of benign pancreatic neuroendocrine tumors
The study was prospective and retrospective, non-randomized study included patients with benign pancreatic neoplasms. The robotic arm consecutively includes patients underwent robotic enucleation surgery and expected number in this arm is 50. The laparoscopic and open surgery arms retrospectively include case from the year 2004. The number of patients for laparoscopic and open surgery arms are 50 and 100, respectively.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
156
Robotic surgery: enucleation benign Pancreatic Neuroendocrine Tumors
Laparoscopic surgery: enucleation benign Pancreatic Neuroendocrine Tumors
Open surgery: enucleation benign Pancreatic Neuroendocrine Tumors
Department of General Surgery, Peking Union medical school hospital
Beijing, Beijing Municipality, China
Pancreatic fistula rate
Time frame: up to 30 days
Mortality rate
Time frame: up to 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.